Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter, Fiscal Year Ending February 28, 2022 and Fiscal Year 2023
January 10, 2022 at 04:30 pm EST
Share
Accolade, Inc. provided earnings guidance for the fourth quarter, fiscal year ending February 28, 2022 and fiscal year 2023. For the quarter, The company expects revenue in the range of $90 million to $93 million, representing a year-over-year growth rate of 138% and 13% on a pro forma basis.
For the year 2022, The company expects revenue in the range of $306 million to $309 million, representing 81% growth over the prior year at the midpoint and 30% on a pro forma basis.
For the year 2023, The company expects project revenue will grow approximately 25% over fiscal year 2022 to about $385 million.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.